Advanced HR - Positive, HER2 - Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced HR - Positive, HER2 - Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer (NCT06856200) | Fudan University | 2025-02-28 |
Track Advanced HR - Positive, HER2 - Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.